05:54 PM EDT, 03/13/2024 (MT Newswires) -- Lexeo Therapeutics ( LXEO ) said Wednesday it sold 6.3 million common shares in a private placement at $15.13 each, for gross proceeds of $95 million.
The company said it plans to use the net proceeds to fund ongoing clinical-stage programs, for working capital and general corporate purposes.